γ-Secretase inhibitor I induces apoptosis in chronic lymphocytic leukemia cells by proteasome inhibition, endoplasmic reticulum stress increase and notch down-regulation. (Q46067297)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	γ-Secretase inhibitor I induces apoptosis in chronic lymphocytic leukemia cells by proteasome inhibition, endoplasmic reticulum stress increase and notch down-regulation.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23001755%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

γ-Secretase inhibitor I induces apoptosis in chronic lymphocytic leukemia cells by proteasome inhibition, endoplasmic reticulum stress increase and notch down-regulation (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23001755%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

0 references

endoplasmic reticulum

0 references

1 reference

based on heuristic

inferred from title

chronic lymphocytic leukemia

1 reference

based on heuristic

inferred from title

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23001755%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Emanuela Rosati

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23001755%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Filomena De Falco

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23001755%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Beatrice Del Papa

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23001755%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Katia Fettucciari

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23001755%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

author name string

Rita Sabatini

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23001755%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Franca Falzetti

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23001755%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Mauro Di Ianni

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23001755%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Laura Cavalli

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23001755%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Isabella Screpanti

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23001755%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Pierfrancesco Marconi

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23001755%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

language of work or name

0 references

publication date

17 October 2012

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23001755%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

International Journal of Cancer

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23001755%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

132

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23001755%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23001755%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

1940-1953

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23001755%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27863

21 January 2018

Targeting multiple kinase pathways: a change in paradigm

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27863

21 January 2018

From single- to multi-target drugs in cancer therapy: when aspecificity becomes an advantage.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27863

21 January 2018

Rational targeting of Notch signaling in cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27863

21 January 2018

Recent insights into the role of Notch signaling in tumorigenesis

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27863

21 January 2018

Mechanisms and clinical prospects of Notch inhibitors in the therapy of hematological malignancies

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27863

21 January 2018

Targeting the NF-kappaB signaling pathway in Notch1-induced T-cell leukemia.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27863

21 January 2018

In vitro validation of gamma-secretase inhibitors alone or in combination with other anti-cancer drugs for the treatment of T-cell acute lymphoblastic leukemia.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27863

21 January 2018

Targeting both Notch and ErbB-2 signalling pathways is required for prevention of ErbB-2-positive breast tumour recurrence

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27863

21 January 2018

Inhibition of gamma-secretase induces G2/M arrest and triggers apoptosis in breast cancer cells

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27863

21 January 2018

The cytotoxicity of gamma-secretase inhibitor I to breast cancer cells is mediated by proteasome inhibition, not by gamma-secretase inhibition.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27863

21 January 2018

z-Leucinyl-leucinyl-norleucinal induces apoptosis of human glioblastoma tumor-initiating cells by proteasome inhibition and mitotic arrest response

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27863

21 January 2018

GSI-I (Z-LLNle-CHO) inhibits γ-secretase and the proteosome to trigger cell death in precursor-B acute lymphoblastic leukemia.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27863

21 January 2018

Phase II study of single-agent bortezomib for the treatment of patients with fludarabine-refractory B-cell chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27863

21 January 2018

Proteasome-dependent endoplasmic reticulum-associated protein degradation: an unconventional route to a familiar fate

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27863

21 January 2018

Proteasome inhibitor induces apoptosis through induction of endoplasmic reticulum stress.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27863

21 January 2018

Novel targets for endoplasmic reticulum stress-induced apoptosis in B-CLL.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27863

21 January 2018

Targeting endoplasmic reticulum protein transport: a novel strategy to kill malignant B cells and overcome fludarabine resistance in CLL.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27863

21 January 2018

Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27863

21 January 2018

A clinical staging system for chronic lymphocytic leukemia: prognostic significance.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27863

21 January 2018

Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27863

21 January 2018

ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27863

21 January 2018

A new genetic lesion in B-CLL: a NOTCH1 PEST domain mutation.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27863

21 January 2018

Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27863

21 January 2018

Diverse marrow stromal cells protect CLL cells from spontaneous and drug-induced apoptosis: development of a reliable and reproducible system to assess stromal cell adhesion-mediated drug resistance

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27863

21 January 2018

Mechanisms of proteasome inhibitor action and resistance in cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27863

21 January 2018

Roles of CHOP/GADD153 in endoplasmic reticulum stress

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27863

21 January 2018

Caspase cleavage product of BAP31 induces mitochondrial fission through endoplasmic reticulum calcium signals, enhancing cytochrome c release to the cytosol

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27863

21 January 2018

Coupling of stress in the ER to activation of JNK protein kinases by transmembrane protein kinase IRE1

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27863

21 January 2018

Mitochondria and endoplasmic reticulum: the lethal interorganelle cross-talk

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27863

21 January 2018

Bodyguards and assassins: Bcl-2 family proteins and apoptosis control in chronic lymphocytic leukaemia.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27863

21 January 2018

Mcl-1 expression has in vitro and in vivo significance in chronic lymphocytic leukemia and is associated with other poor prognostic markers.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27863

21 January 2018

The Akt/Mcl-1 pathway plays a prominent role in mediating antiapoptotic signals downstream of the B-cell receptor in chronic lymphocytic leukemia B cells

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27863

21 January 2018

Elimination of Mcl-1 is required for the initiation of apoptosis following ultraviolet irradiation

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27863

21 January 2018

Ets-1 mediates upregulation of Mcl-1 downstream of XBP-1 in human melanoma cells upon ER stress.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27863

21 January 2018

Differential Noxa/Mcl-1 balance in peripheral versus lymph node chronic lymphocytic leukemia cells correlates with survival capacity

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27863

21 January 2018

BCL-2 family regulation by the 20S proteasome inhibitor bortezomib

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27863

21 January 2018

Role of NOXA and its ubiquitination in proteasome inhibitor-induced apoptosis in chronic lymphocytic leukemia cells

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27863

21 January 2018

Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27863

21 January 2018

SEL-10 is an inhibitor of notch signaling that targets notch for ubiquitin-mediated protein degradation

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27863

21 January 2018

Notch1 as a potential therapeutic target in cutaneous T-cell lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27863

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46067297&oldid=1534919196"